InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
31%
T+90 mean return
-7.7%
Across 35 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Kulkarni Samarth, Chairman & CEO. Insider active across 1 company, notably CRISPR Therapeutics AG. In total, 49 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €3m. Activity tracked since 1 June 2021. The latest transaction was filed on 19 February 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations49 total
19,688 sharesCommon SharesSEC:0000950170-25-043975:0
19,250 sharesCommon SharesSEC:0000950170-25-038216:0
18,360 shares@ US$55.2058.5% of flowCommon SharesSEC:0000950170-25-025000:0
13,250 sharesCommon SharesSEC:0000950170-25-023385:0
13,751 shares@ US$16.211.9% of flowCommon SharesSEC:0000950170-24-140846:0
15,000 shares@ US$55.10436.8% of flowCommon SharesSEC:0000950170-24-133373:0
23,121 shares@ US$55.4310.4% of flowCommon SharesSEC:0000950170-24-126521:0
8,333 sharesCommon SharesSEC:0000950170-24-114786:0
100,000 shares0Common SharesSEC:0000950170-24-095615:0
19,582 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-045196:0
20,000 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-032989:0
19,250 sharesCommon SharesSEC:0000950170-24-030189:0
13,250 sharesCommon SharesSEC:0000950170-24-018174:0
20,000 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-016574:0
50,000 shares@ US$19.127.7% of flowCommon SharesSEC:0000950170-24-009505:0
20,000 shares@ US$19.123.1% of flowCommon SharesSEC:0000950170-24-005492:0
25,000 shares@ US$19.123.9% of flowCommon SharesSEC:0001209191-23-033394:0
25,000 shares@ US$19.123.8% of flowCommon SharesSEC:0001209191-23-025901:0
25,000 shares@ US$19.123.8% of flowCommon SharesSEC:0001209191-23-021911:0
11,833 sharesCommon SharesSEC:0001209191-23-018566:0
25,000 shares@ US$19.124.0% of flowCommon SharesSEC:0001209191-23-014273:0
13,250 sharesCommon SharesSEC:0001209191-23-011782:0
25,000 shares@ US$19.123.8% of flowCommon SharesSEC:0001209191-23-005769:0
25,000 shares@ US$19.123.9% of flowCommon SharesSEC:0001209191-22-063026:0
58,233 shares@ US$1.810.9% of flowCommon SharesSEC:0001209191-22-060387:0
25 of 49 declarations
About Kulkarni Samarth
Samarth Kulkarni is an executive at CRISPR Therapeutics AG.
